← Open Payments lookup

SARAH KANTELIS: Open Payments

NPI 1881047892 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$8,807 in 212 payments from 19 companies in 2025. Trend: 2023 $6,118 · 2024 $2,971 · 2025 $8,807

Food & beverage: $5,057Speaker / faculty: $3,750
CompanyPaymentsAmount
ABBVIE INC.30$4,274
Vanda Pharmaceuticals Inc.27$954
Neurocrine BioSciences, Inc.17$509
Otsuka America Pharmaceutical, Inc.22$440
Teva Pharmaceuticals USA, Inc.19$410
E.R. Squibb & Sons, L.L.C.14$393
Janssen Pharmaceuticals, Inc11$374
Alkermes, Inc.15$255
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$251
Axsome Therapeutics, Inc.8$217

Products named: VRAYLAR, HETLIOZ, INGREZZA, COBENFY, REXULTI, AUSTEDO XR, SPRAVATO, ARISTADA.

Industry payments across CA — which companies pay providers there.